Burning Rock Biotech Limited Research and Development Expense
Burning Rock Biotech Limited (BNR) reported Research and Development Expense of CNY 166.49 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-28
CNY
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | 166.49M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | 232.29M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | 347.02M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 421.87M CNY 20-F · filed 2025-04-29 | |
| 2022-06-30 | 211.61M CNY 6-K · filed 2022-11-07 | |
| 2021-12-31 | 367.86M CNY 20-F · filed 2024-04-29 | |
| 2021-06-30 | 185.49M CNY 6-K · filed 2022-11-07 | |
| 2020-12-31 | 263.94M CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 156.94M CNY 20-F · filed 2022-04-29 | |
| 2018-12-31 | 105.30M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $23.81M 20-F · filed 2026-04-28 | |
| 2024-12-31 | $31.82M 20-F · filed 2025-04-29 | |
| 2023-12-31 | $48.88M 20-F · filed 2024-04-29 | |
| 2022-12-31 | $61.16M 20-F · filed 2023-04-20 | |
| 2022-06-30 | $31.59M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $57.73M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $40.45M 20-F · filed 2021-03-23 |